GOAL: Establish Breast Cancer Index as the standard biomarker test for all women with HR+ cancer.

Before Breast Cancer Index, nearly 95% of women with HR+ breast cancer were undergoing unnecessary treatment with debilitating side effects. This groundbreaking solution allowed oncologists to determine who would actually benefit from treatment and prescribe with greater precision. However, providers were largely unaware of the test and already flooded with pharma messaging — so to capture their attention, we turned patients, caregivers, and key opinion leaders into advocates. Not Another Minute™ took a stance to end the suffering, creating life-changing clarity for those who needed it most.